Improving outcomes in patients with oesophageal cancer

Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

Article  PubMed  Google Scholar 

Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer Statistics, 2023. CA Cancer J. Clin. 73, 17–48 (2023).

Article  PubMed  Google Scholar 

Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer Statistics, 2021. CA Cancer J. Clin. 71, 7–33 (2021).

Article  PubMed  Google Scholar 

He, H. et al. Trends in the incidence and survival of patients with esophageal cancer: a SEER database analysis. Thorac. Cancer 11, 1121–1128 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Njei, B., McCarty, T. R. & Birk, J. W. Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis. J. Gastroenterol. Hepatol. 31, 1141–1146 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Arnold, M., Soerjomataram, I., Henegouwen, M. B. & Soerjomataram, I. Global incidence of oesophageal cancer and gastric cancer by histology and subsite in 2018. Gut 69, 1564–1571 (2020).

Article  PubMed  Google Scholar 

Abnet, C. C., Arnold, M. & Wei, W. Q. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology 154, 360–373 (2018).

Article  PubMed  Google Scholar 

Zang, Z. et al. Dietary patterns and severity of symptom with the risk of esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional latent class analysis. BMC Cancer 22, 95 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCormack, V. A. et al. Informing etiologic research priorities for squamous cell esophageal cancer in Africa: a review of setting-specific exposures to known and putative risk factors. Int. J. Cancer 140, 259–271 (2017).

Article  CAS  PubMed  Google Scholar 

Lin, Y. et al. Esophageal cancer in high-risk areas of China: research progress and challenges. Ann. Epidemiol. 27, 215–222 (2017).

Article  PubMed  Google Scholar 

Arnal, M. J. D., Arenas, A. F. & Arbeloa, A. L. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J. Gastroenterol. 21, 7933–7943 (2015).

Article  Google Scholar 

Shah, M. A. et al. Treatment of locally advanced esophageal carcinoma: ASCO guideline. J. Clin. Oncol. 38, 2677–2694 (2020).

Article  PubMed  Google Scholar 

Kojima, T. et al. Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer. J. Clin. Oncol. 38, 4138–4148 (2020).

Article  CAS  PubMed  Google Scholar 

Shah, M. A. et al. Efficacy and safety of pembrolizumab for heavily pretreated patients with advanced, metastateic adenocarcinoma or squamous cell carcinoma of the esophagus: the phase 2 KEYNOTE-180 study. JAMA Oncol. 5, 546–550 (2019).

Article  PubMed  Google Scholar 

Janjigian, Y. Y. et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastroesophageal junction, and oesophageal adenocarcioma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet 398, 27–40 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shitara, K. et al. Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer. Nature 603, 942–948 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun, J. et al. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study. Lancet 398, 759–771 (2021).

Article  CAS  PubMed  Google Scholar 

Doki, Y., Ajani, J. A., Kato, K. & Xu, J. Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma. N. Engl. J. Med. 386, 449–462 (2022).

Article  CAS  PubMed  Google Scholar 

Kelly, R. J. et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N. Engl. J. Med. 384, 1191–1203 (2021).

Article  CAS  PubMed  Google Scholar 

Janjigian, Y. Y. et al. The KEYNOTE-811 trial of dual PD-1 and HER2 blockade for HER2-positive gastric cancer. Nature 600, 727–730 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shitara, K. et al. Trastuzumab deruxtecan in previously treated HER2-positive gastric cancer. N. Engl. J. Med. 382, 2419–2430 (2020).

Article  CAS  PubMed  Google Scholar 

Shah, M. A. et al. Immunotherapy and targeted therapy for advanced gastroesophageal cancer: ASCO guideline. J. Clin. Oncol. 41, 1470–1491 (2023).

Article  CAS  PubMed  Google Scholar 

The Cancer Genome Atlas Research Network. Integrated genomic characterization of oesophageal carcinoma. Nature 541, 169–175 (2017).

Article  PubMed Central  Google Scholar 

Campbell, J. D. et al. Genomic, pathway network, and immunologic features distinguishing squamous carcinomas. Cell Rep. 23, 194–212 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quante, M., Wang, T. C. & Bass, A. J. Adenocarcinoma of the oesophagus: is it gastric cancer? Gut https://doi.org/10.1136/gutjnl-2022-327096 (2022).

Article  PubMed  Google Scholar 

Dotto, G. P. & Rustgi, A. K. Squamous cell cancers: a unified perspective on biology and genetics. Cancer Cell 29, 622–637 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yokoyama, T. et al. Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men. Cancer Epidemiol. Biomarkers Prev. 12, 1227–1233 (2003).

CAS  PubMed  Google Scholar 

Wang, G. Q. et al. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 54, 187–192 (2005).

Article  PubMed  PubMed Central  Google Scholar 

Liu, X. et al. Genetic alterations in esophageal tissues from squamous dysplasia to carcinoma. Gastroenterology 153, 166–177 (2017).

Article  CAS  PubMed  Google Scholar 

Liao, G. et al. Single-cell transcriptomics provides insights into the origin and microenvironment of human oesophageal high-grade intraepithelial neoplasia. Clin. Transl. Med. 12, e874 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Que, J., Garman, K. S., Souza, R. F. & Spechler, S. J. Pathogenesis and cells of origin of Barrett’s esophagus. Gastroenterology 157, 349–364.e1 (2019).

Article  PubMed  Google Scholar 

Nowicki-Osuch, K. et al. Molecular phenotyping reveals the identity of Barrett’s esophagus and its malignant transition. Science 373, 760–767 (2021).

Article  CAS  PubMed  Google Scholar 

Sawas, T. et al. Magnitude and time-trend analysis of postendoscopy esophageal adenocarcinoma: a systemic review and meta-analysis. Clin. Gastroenterol. Hepatol. 20, e31–e50 (2022).

Article  PubMed  Google Scholar 

Sawas, T. et al. Identification of prognostic phenotypes of esophageal adenocarcinoma in 2 independent cohorts. Gastroenterology 155, 1720–1728 (2018).

Article  PubMed  Google Scholar 

Stachler, M. D. et al. Detection of mutations in Barrett’s esophagus before progression to high-grade dysplasia or adenocarcinoma. Gastroenterology 155, 156–167 (2018).

Article  CAS  PubMed  Google Scholar 

Killcoyne, S. et al. Genomic copy number predicts esophageal cancer years before transformation. Nat. Med. 26, 1726–1732 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fitzgerald, R. C. et al. Cytosponge-trefoil factor 3 versus usual care to identify Barrett’s oesophagus in a primary care setting: a multicenter, pragmatic, randomised controlled trial. Lancet 396, 333–344 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Wu, W. et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology 144, 956–966 (2013).

Article  CAS  PubMed  Google Scholar 

Jammula, S. et al. Identification of subtypes of Barrett’s esophagus and esophageal adenocarcinoma based on DNA methylation profiles and integration of transcriptome and genome data. Gastroenterology 158, 1682–1697 (2020).

留言 (0)

沒有登入
gif